This announcement is a separate document:
康諾亞-B：2023中期報告
KEYMED BIO-B: 2023 INTERIM REPORT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.